10x Genomics Operating Income 2018-2026 | TXG
10x Genomics annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- 10x Genomics operating income for the quarter ending June 30, 2026 was $-0.020B, a 164.91% decline year-over-year.
- 10x Genomics operating income for the twelve months ending June 30, 2026 was $-0.088B, a 12.08% decline year-over-year.
- 10x Genomics annual operating income for 2025 was $-0.061B, a 68.65% decline from 2024.
- 10x Genomics annual operating income for 2024 was $-0.195B, a 26.67% decline from 2023.
- 10x Genomics annual operating income for 2023 was $-0.265B, a 57.99% increase from 2022.
|
10x Genomics Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $-61 |
| 2024 | $-195 |
| 2023 | $-265 |
| 2022 | $-168 |
| 2021 | $-52 |
| 2020 | $-534 |
| 2019 | $-31 |
| 2018 | $-111 |
| 2017 | $-18 |
|
10x Genomics Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2026-06-30 | $-20 |
| 2026-03-31 | $-17 |
| 2025-12-31 | $-20 |
| 2025-09-30 | $-32 |
| 2025-06-30 | $30 |
| 2025-03-31 | $-39 |
| 2024-12-31 | $-50 |
| 2024-09-30 | $-41 |
| 2024-06-30 | $-42 |
| 2024-03-31 | $-61 |
| 2023-12-31 | $-55 |
| 2023-09-30 | $-95 |
| 2023-06-30 | $-63 |
| 2023-03-31 | $-52 |
| 2022-12-31 | $-23 |
| 2022-09-30 | $-40 |
| 2022-06-30 | $-63 |
| 2022-03-31 | $-42 |
| 2021-12-31 | $-16 |
| 2021-09-30 | $-16 |
| 2021-06-30 | $-10 |
| 2021-03-31 | $-10 |
| 2020-12-31 | $-410 |
| 2020-09-30 | $-65 |
| 2020-06-30 | $-39 |
| 2020-03-31 | $-20 |
| 2019-12-31 | $-8 |
| 2019-09-30 | $-9 |
| 2019-06-30 | $-10 |
| 2019-03-31 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $9.135B | $0.643B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |